Two Seas Capital LP 13D and 13G filings for Arbutus Biopharma Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 08:41 am Sale |
2024-09-30 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 8,387,388 4.400% |
-654,539 (-7.24%) |
Filing |
| 2024-02-14 10:48 am Sale |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,041,927 5.400% |
-461,176 (-4.85%) |
Filing |
| 2023-11-21 08:00 am Purchase |
2023-11-21 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,503,103 5.700% |
9,503,103 (New Position) |
Filing |